Woman and Man
- | Country :
- Canada
- Germany
- United States
- The 3 others...
- | organs : -
- | Specialty : -
Extract
The purpose of this study is to assess the safety and efficacy of ABT-493/ABT-530 following 12 weeks of treatment in adults with chronic Hepatitis C Virus Infection genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis.
Inclusion criteria
- Hepatitis C Virus Infection ,Chronic hepatitis C ,Compensated Cirrhosis